Nonspecific Cutaneous Manifestations of Systemic Lupus Erythematosus

  • Thomas T. Provost


Systemic Lupus Erythematosus Mixed Connective Tissue Disease Acanthosis Nigricans Porphyria Cutanea Tarda Epidermolysis Bullosa Acquisita 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alarcon-Segovia D, Babb RR, Fairbairn JF (1963) Systemic lupus erythematosus and erythromyalgias. Ann Intern Med 112:102–106Google Scholar
  2. Aoki T, Ishizawa T, Hozumi Y, Aso K, Kondo S (1996) Chilblain lupus erythematosus of Hutchinson responding to surgical treatment: a report of two patients with anti Ro/SS-A antibodies. British J Dermatol 134:533–537CrossRefGoogle Scholar
  3. Bielsa I, Herrero C, Font J, Mascaro JM (1987) Lupus erythematosus and toxic epidermal necrolysis. J Am Acad Dermatol 16:1265–1267PubMedGoogle Scholar
  4. Boire G, Menard HA, Gendron M, Lussier A, Myhal D (1993) Rheumatoid arthritis: anti Ro antibodies define a non HLA-DR4 associated clinical serological cluster. J Rheumatol 20:1654–1660PubMedGoogle Scholar
  5. Boire G, Menard HA (1988) Clinical significance of anti-Ro (SS-A) antibody in rheumatoid arthritis. J Rheumatol 15:391–394PubMedGoogle Scholar
  6. Callen J, Ross L(1981) Subacute cutaneous lupus in porphyria cutanea tarda. J Am Acad Dermatol 5:269–273PubMedGoogle Scholar
  7. Chorzelski T, Jablonska S, Blasczyk M (1968) Immunopathological investigations in the Senear Usher syndrome (coexistence of pemphigus and lupus erythematosus). Br J Dermatol 80:211–217PubMedGoogle Scholar
  8. Clemmenson O, Thomasen K (1982) Porphyria cutanea tarda in systemic lupus erythematosus. Arch Dermatol 118:160–162CrossRefPubMedGoogle Scholar
  9. Cohen JS (2000) Erythromelalgia: new theories and new therapies. J Am Acad Dermatol 43:841–847CrossRefPubMedGoogle Scholar
  10. Cohen S, Stastny P, Sontheimer RD (1986) Concurrence of subacute cutaneous lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 29:421–425PubMedGoogle Scholar
  11. Collier DH, Lee LA (2000) Three generations of patients with lupus erythematosus and hereditary angioedema. Am J Med 109:256–257CrossRefPubMedGoogle Scholar
  12. Cram DL, Epstein JH, Tuffanelli DL (1973) Lupus erythematosus in porphyria: coexistence in 7 patients. Arch Dermatol 108:779–784CrossRefPubMedGoogle Scholar
  13. Cribier B, Djeridi N, Peltre B, Grosshans E (2001) A histologic and immunohistochemical study of chilblains. J Am Acad Dermatol 45: 924–929CrossRefPubMedGoogle Scholar
  14. Cruz PD Jr, Colison BM, Sontheimer RD (1987) Concurrentfe atures of cutaneous lupus erythematosus following myosthenia gravis and thymoma. J Am Acad Dermatol 16:472–480PubMedGoogle Scholar
  15. DeBracco MM, Bianchi CA, Bianchi O (1979) Hereditary complement (C2) deficiency with discoid lupus erythematosus and idiopathic anetoderma. Int J Dermatol 18:713–717PubMedGoogle Scholar
  16. Diment J, Ginzler E, Schleisinger M, Sterba G, Diamond H, Kaplan D, Weiner M (1979) The clinical significance of Raynauds phenomenon in systemic lupus erythematosus. Arthritis 22:815–819Google Scholar
  17. Dubois EL, Tuffanelli DL (1964) Clinical manifestations of systemic lupus erythematosus. JAMA 190:104–107PubMedGoogle Scholar
  18. Estes D, Christian CL (1971) The natural history of systemic lupus erythematosus by prospective analysis. Medicine 50:85–95PubMedGoogle Scholar
  19. Euwer RL, Sontheimer RD (1991) Amyopathic dermatomyositis (dermatomyositis sine myositis). J Am Acad Dermatol 24:959–966PubMedGoogle Scholar
  20. Franceschini F, Calzavara-Pinton P, Quinzanini M, Cavazzana I, Bettoni L, Zane C, Faccheti F, Airo P, McCauliffe DP, Cattanes R(1999) Chilblain lupus erythematosus is associated with antibodies to SSA/Ro. Lupus 8:215–219CrossRefPubMedGoogle Scholar
  21. Gammon WR, Briggaman RA (1993) Bullous SLE: a phenotypically distinctivebut immunologic heterogeneous bullous disorder. J Invest Dermatol 100: 28S–34SCrossRefPubMedGoogle Scholar
  22. Gammon WR, Woodley D, Dole KC, Briggaman RA (1985) Evidencethat anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen. J Invest Dermatol 84:472–476CrossRefPubMedGoogle Scholar
  23. Gilliam JM, Cohen SB, Sontheimer RD, Moscella SL (1985) Connective tissue diseases. In: Moscella SL, Hurley HJ (eds) Dermatology, WB Saunders, Philadelphia, 1087–1135Google Scholar
  24. Hall RP, Lawley TJ, Smith HR, Katz SI (1982) Bullous eruption of systemic lupus erythematosus. Ann Intern Med 97:165–170PubMedGoogle Scholar
  25. Hochberg MC, Boyd RB, Ahearn JM, Arnett FC, Bias WB, Provost TT, Stevens MB (1985) Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographics subsets. Medicine 64:285–295PubMedGoogle Scholar
  26. Kabir JDI, Malkinson FD (1969) Lupus erythematosus and calcinosis cutis. Arch Dermatol 100:17–22CrossRefPubMedGoogle Scholar
  27. Kallenberg CS, Wouda AA, The TH (1980) Systemic involvement and immunologic findings in patients presenting with Raynaud’s phenomenon. Am J Med 69:675–680CrossRefPubMedGoogle Scholar
  28. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV (1995) The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 332:993–997CrossRefPubMedGoogle Scholar
  29. Kohler PF, Percy J, Campion WM, Smyth CJ (1974) Hereditary angioedema and “familial” lupus erythematosus in identical twin bodies. Am J Med 56:406–411CrossRefPubMedGoogle Scholar
  30. Kuhn A, Sonntag M, Richter-Hintz D, Oslislo C, Megahed M, Ruzicka T, Lehmann P (2001) Phototesting in lupus erythematosus: a 15 year experience. J Am Acad Dermatol 45:86–95CrossRefPubMedGoogle Scholar
  31. Levine JS (2002) The antiphospholipid syndrome. N Eng J Med 346:752–763CrossRefGoogle Scholar
  32. Levine SR, Langer SL, Albers JW, Welch KMA (1988) Sneddon’s syndrome: an antiphospholipid antibody syndrome. Neurology 38:798–800PubMedGoogle Scholar
  33. Maddison PJ, Mogavero H, Reichlin M(1978) Patterns of clinical disease associated with antibodies to nuclear ribonucleo protein. J Rheumatol 5: 407–411PubMedGoogle Scholar
  34. Maruyama M, Miyaychi S, Hashimoto K (1997) Massive cutaneous mucinosis associated with systemic lupus erythematosus. Br J Dermatol 137:450–453CrossRefPubMedGoogle Scholar
  35. Millard LG, Rowell NR (1978) Chilblain lupus erythematosus (Hutchinson). Br J Dermatol 98:497–506PubMedGoogle Scholar
  36. Mond CB, Peterson MGE, Rothfield NF (1989) Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients. Arthritis Rheum 32:202–204PubMedGoogle Scholar
  37. Nishikawa T, Provost TT (1991) Difference in clinical serological and immunogenetic features of White versus Oriental anti-Ro (SS-A) antibody positive patients. J Am Acad Dermatol 25:563–564PubMedGoogle Scholar
  38. O’Laughlin S, Schroeter AL, Jordon RE (1978) Chronic urticaria-like lesions in systemic lupus erythematosus. Arch Dermatol 114:879–883CrossRefPubMedGoogle Scholar
  39. Pistiner M, Wallace DJ, Nessim S, Metzger AL (1991) Lupus erythematosus in the 1980’s: a survey of 570 patients. Sem in Arthritis Rheum 21:55–64CrossRefGoogle Scholar
  40. Provost TT, Watson R, Simmons-O’Brien E (1996) Significance of the anti-Ro (SS-A) antibodyin evaluation of patients with cutaneous manifestations of a connective tissue disease. J Am Acad Dermatol 35:147–169CrossRefPubMedGoogle Scholar
  41. Provost TT, Watson RM, Gammon WR, Reichlin M (1987) The neonatal lupus syndrome associated with U1RNP antibodies. N Eng J Med 316: 1135–1138Google Scholar
  42. Provost TT, Zone JJ, Synkowski DL, Maddison PJ, Reichlin M (1980) Unusual cutaneous manifestation of systemic lupus erythematosus: urticarial-like lesions. J Invest Dermatol 75:495–499CrossRefPubMedGoogle Scholar
  43. Randle HW, Muller S (1983) Generalized elastolysis associated with systemic lupus erythematosus. J Am Acad Dermatol 8:869–873PubMedGoogle Scholar
  44. Rendon MI, Cruz PD, Sontheimer RD, Bergstresser RD (1989) Acanthosis nigricans: a cutaneous marker of tissue resistanceto insulin. J Am Acad Dermatol 21:461–469PubMedGoogle Scholar
  45. Roubey RAS (1996) Immunology of antiphospholipid syndrome. Arthritis Rheum 39:1444–1454PubMedGoogle Scholar
  46. Rowell NR, Swanson-Beck J, Anderson JR (1963) Lupus erythematosus and erythema multiforme-like lesions. Arch Dermatol 88:176–180PubMedGoogle Scholar
  47. Ruzicka T, Faes J, Bergner T (1991) Annular erythema associated with Sjögren’s syndrome: a variant of systemic lupus erythematosus. J Am Acad Dermatol 25:557–560PubMedGoogle Scholar
  48. Sharp GC, Irvin WS, May CM (1976) Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective tissue disease systemic lupus erythematosus and other rheumatic diseases. N Engl J Med 295: 1149–1154PubMedGoogle Scholar
  49. Shu U, Mannik M (1988) Low molecular weight C1q binding immunoglobulin G in patients with systemic lupus erythematosus consists of antibodies to collagen-like region of C1q. Clin Invest 82:816–820Google Scholar
  50. Simmons-O’Brien E, Chen S, Watson R, Provost TT (1995) 100 anti-Ro (SS-A) antibody positive patients: a ten year follow up. Medicine 74: 109–130CrossRefPubMedGoogle Scholar
  51. Sneddon IB (1965) Cerebro-vascular lesions and livedo reticularis. Br J Dermatol 77:180–185PubMedGoogle Scholar
  52. Sontheimer RD, Provost TT (1996) Lupus erythematosus. In: Sontheimer RD, Provost TT (eds) Cutaneous manifestations of rheumatic diseases. Williams & Wilkins, Baltimore, pp 1–71Google Scholar
  53. Stonecipher MR, Jorrigo JL, White WL, Walker FO (1993) Cutaneous changes of dermatomyositis in patients with normal enzymes: dermatomyositis sine myositis. J Am Acad Dermatol 28:951–956PubMedGoogle Scholar
  54. Teramato N, Katayama A, Arai H (1989) Annular erythema: a possible association with primary Sjögren’s syndrome. J Am Acad Dermatol 20:596–601PubMedGoogle Scholar
  55. Trendelenburg M, Courvoisier S, Späth PJ, Moll S, Mihatsch M, Itin P, Schifferli JA (1999) Hypocomplementemic urticarial vasculitis or systemic lupus erythematosus. Am J Kidney Dis 34:745–751PubMedGoogle Scholar
  56. Urowitz MB, Gladmann DD, Chalmers A, Ogryzlo MA (1978) Nail lesions in systemic lupus erythematosus. J Rheumatol 5:441–447PubMedGoogle Scholar
  57. van der Horst JC, Cirkel PKS, Niebore C (1983) Mixed lichen planus — lupus erythematosus disease — a distinct entity? Clinical, histopathologic, and immunopathological studies in 6 patients. Clin Exp Dermatol 8:631–640PubMedGoogle Scholar
  58. Vaughn RY, Bailey JP Jr, Field RS, Loebl DH, Mealing HG Jr, Jerath RS, Dorlon RE (1990) Diffuse nail dyschromia in black patients with systemic lupus erythematosus. J Rheumatol 16:640–643Google Scholar
  59. Viguier M, Pinqirier L, Cavelier-Balloy B, Salmoniere P, Cordoliani F, Flageul B, Morel P, Dubertrt L, Bachelez H (2001) Clinical and histopathologic features and immunologic variables in patients with severe chilblains: a study of the relationship to lupus erythematosus. Medicine 80:180–188CrossRefPubMedGoogle Scholar
  60. Watanbe T, Tsuchida T, Ito Y, Kanda N, Ueda Y, Tamaki K (1997) Annular erythema associated with lupus erythematosus/Sjögren’s syndrome. J Am Acad Dermatol 36:214–218PubMedGoogle Scholar
  61. Weatherhead L, Adam J (1985) Discoid lupus erythematosus: coexistence with porphyria cutanea tarda. Int J Dermatol 108:453–455Google Scholar
  62. Wisnieski JJ, Jones SM (1992) Comparison of autoantibodies to collagen-like region of C1q in hypcomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. J Immunol 148:1396–1403PubMedGoogle Scholar
  63. Yasue T (1986) Lividoid vasculitis and central nervous system involvement in systemic lupus erythematosus. Arch Dermatol 122:66–70CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 2005

Authors and Affiliations

  • Thomas T. Provost

There are no affiliations available

Personalised recommendations